Home › Research › Risk factors
Comparison of plasma p‐tau217 and Aβ42/Aβ40 biomarkers by race to detect Alzheimer’s disease
Katheryn A Q Cousins, Magdalena Korecka, Yang Wan, Amberley Vulaj, Christopher D. Brown, Thomas Francis Tropea, Alice S. Chen‐Plotkin, Eddie B Lee et al.. Alzheimer s & Dementia, 2024-12-01
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Results P‐tau217/Aβ42 had the highest performance to discriminate Aβ+ from Aβ‐ (Table 1A,1B; all AUC≥0.90), and p‐tau217 showed excellent accuracy in ADNI sample (0.96; Table 1B). Linear models showed that Black individuals had significantly higher Aβ42 (β = 0.098, p = 0.0014); no difference was observed for p‐tau217 or p‐tau217/Aβ42 (both p≥0.43) (Figure 1).
What this study adds
Evidence grade: Low
The record lists 213 participants. This study compared plasma p-tau217 and Aβ42/Aβ40 biomarkers by race to detect Alzheimer's disease. It found that p-tau217/Aβ42 had the highest performance to discriminate Aβ+ from Aβ-, and that Black individuals had significantly higher Aβ42 while no difference was observed for p-tau217 or p-tau217/Aβ42.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Cousins, K. A. Q., Korecka, M., Wan, Y., Vulaj, A., Brown, C. D., Tropea, T. F., et al. (2024). Comparison of plasma p‐tau217 and Aβ42/Aβ40 biomarkers by race to detect Alzheimer’s disease. Alzheimer s & Dementia. https://doi.org/10.1002/alz.094605
Vancouver
Cousins KAQ, Korecka M, Wan Y, Vulaj A, Brown CD, Tropea TF, et al. Comparison of plasma p‐tau217 and Aβ42/Aβ40 biomarkers by race to detect Alzheimer’s disease. Alzheimer s & Dementia. 2024. doi:10.1002/alz.094605.
BibTeX
@article{cousins2024-cb9b4953,
author = {Cousins, Katheryn A Q and Korecka, Magdalena and Wan, Yang and Vulaj, Amberley and Brown, Christopher D. and Tropea, Thomas Francis and Chen‐Plotkin, Alice S. and Lee, Eddie B and others},
title = {{Comparison of plasma p‐tau217 and Aβ42/Aβ40 biomarkers by race to detect Alzheimer’s disease}},
journal = {Alzheimer s \& Dementia},
year = {2024},
doi = {10.1002/alz.094605},
url = {https://doi.org/10.1002/alz.094605}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Results P‐tau217/Aβ42 had the highest performance to discriminate Aβ+ from Aβ‐ (Table 1A,1B; all AUC≥0.90), and p‐tau217 showed excellent accuracy in ADNI sample (0.96; Table 1B).
- Linear models showed that Black individuals had significantly higher Aβ42 (β = 0.098, p = 0.0014); no difference was observed for p‐tau217 or p‐tau217/Aβ42 (both p≥0.43) (Figure 1).
Why it matters
This study compared plasma p-tau217 and Aβ42/Aβ40 biomarkers by race to detect Alzheimer's disease. It found that p-tau217/Aβ42 had the highest performance to discriminate Aβ+ from Aβ-, and that Black individuals had significantly higher Aβ42 while no difference was observed for p-tau217 or p-tau217/Aβ42.
New to this subject? Start with our plain-English guide: Risk factors, ranked →
Study details
- Participants213
- Evidence strengthLow
How this study scored 38/100
Published in a peer-reviewed journal. Scored zero for study design, effect reported and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Alzheimer s & Dementia) |
| Journal's citation record | 2 / 4 | Alzheimer s & Dementia: journal h-index 228 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2024 — within 3 year(s) of the newest study here |
| Sample size | 2 / 4 | 213 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 1 / 7 | Cited 1 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.2 citations a year over 4 year(s) since 2024 |
| Impact for its field and year | 1 / 6 | Cited 0.3× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Leslie M. Shaw: h-index 40 (OpenAlex, whole career) |
| Institution's track record | 2 / 3 | University of Pennsylvania: institution h-index 1,859 (OpenAlex) |
| Multicenter collaboration | 0 / 3 | OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 1 / 2 | Not in PubMed, but has a DOI |
| Free to read | 2 / 2 | Free to read |
| Total | 38 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Risk factors from nearby years
Also tagged “cerebrospinal”
820 studies in the library carry the topic tag “cerebrospinal”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 820 tagged studies.